Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Adonis D'MelloDepartment of Microbiology and Immunology, Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-6995-3617
Timothy F MurphyDivision of Infectious Diseases, Department of Medicine, University at Buffalo, The State University of New York, Buffalo, New York, USA.ORCID 0000-0002-3496-2641
Martina WadeDepartment of Epidemiology of Microbial Diseases, Yale School of Public Heath, New Haven, Connecticut, USA.
Charmaine KirkhamDivision of Infectious Diseases, Department of Medicine, University at Buffalo, The State University of New York, Buffalo, New York, USA.
Yong KongDepartment of Biostatistics, Yale School of Medicine, New Haven, Connecticut, USA.
Hervé Tettelin *Department of Microbiology and Immunology, Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-0615-3257
Melinda M Pettigrew *Division of Environmental Health Sciences, University of Minnesota School of Public Health, Minneapolis, Minnesota, USA.ORCID 0000-0001-8145-7536
Funding
University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Persistent H. influenzae in COPD - virulence, vaccines and antibiotic resistanceR01AI019641 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 1985 to 2023
$7.9M
Clinical and Translational Science Award, University at Buffalo UL1TR001412National Institute of Allergy and Infectious Diseases R01AI19641NCATS NIH HHS UL1 TR001412NIAID NIH HHS R01 AI019641
6 · The paper itself
Abstract
Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease and the third leading cause of death globally. Nontypeable
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Host-pathogen interaction profiling of nontypeable · full record | OpenQuestion